| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |